251 related articles for article (PubMed ID: 33667865)
1. Blood circulation stable doxorubicin prodrug nanoparticles containing hydrazone and thioketal moieties for antitumor chemotherapy.
Xu C; Xu L; Han R; Zhu Y; Zhang J
Colloids Surf B Biointerfaces; 2021 May; 201():111632. PubMed ID: 33667865
[TBL] [Abstract][Full Text] [Related]
2. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
Xu M; Qian J; Liu X; Liu T; Wang H
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
[TBL] [Abstract][Full Text] [Related]
3. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
[TBL] [Abstract][Full Text] [Related]
4. A reactive oxygen species-responsive prodrug micelle with efficient cellular uptake and excellent bioavailability.
Xu L; Yang Y; Zhao M; Gao W; Zhang H; Li S; He B; Pu Y
J Mater Chem B; 2018 Feb; 6(7):1076-1084. PubMed ID: 32254295
[TBL] [Abstract][Full Text] [Related]
5. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
[TBL] [Abstract][Full Text] [Related]
6. Polymeric nanoparticles responsive to intracellular ROS for anticancer drug delivery.
Xu L; Zhao M; Gao W; Yang Y; Zhang J; Pu Y; He B
Colloids Surf B Biointerfaces; 2019 Sep; 181():252-260. PubMed ID: 31153020
[TBL] [Abstract][Full Text] [Related]
7. ROS triggered cleavage of thioketal moiety to dissociate prodrug nanoparticles for chemotherapy.
Pan Q; Deng X; Gao W; Chang J; Pu Y; He B
Colloids Surf B Biointerfaces; 2020 Oct; 194():111223. PubMed ID: 32615519
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
[TBL] [Abstract][Full Text] [Related]
9. A pH-responsive prodrug delivery system self-assembled from acid-labile doxorubicin-conjugated amphiphilic pH-sensitive block copolymers.
Huang X; Liao W; Xie Z; Chen D; Zhang CY
Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():27-37. PubMed ID: 29853091
[TBL] [Abstract][Full Text] [Related]
10. A ROS-responsive polymeric micelle with a π-conjugated thioketal moiety for enhanced drug loading and efficient drug delivery.
Sun C; Liang Y; Hao N; Xu L; Cheng F; Su T; Cao J; Gao W; Pu Y; He B
Org Biomol Chem; 2017 Nov; 15(43):9176-9185. PubMed ID: 29072771
[TBL] [Abstract][Full Text] [Related]
11. Hydrazone linked doxorubicin-PLA prodrug nanoparticles with high drug loading.
Gatti S; Agostini A; Palmiero UC; Colombo C; Peviani M; Biffi A; Moscatelli D
Nanotechnology; 2018 Jul; 29(30):305602. PubMed ID: 29701613
[TBL] [Abstract][Full Text] [Related]
12. A novel delivery system of doxorubicin with high load and pH-responsive release from the nanoparticles of poly (α,β-aspartic acid) derivative.
Wang X; Wu G; Lu C; Zhao W; Wang Y; Fan Y; Gao H; Ma J
Eur J Pharm Sci; 2012 Aug; 47(1):256-64. PubMed ID: 22522116
[TBL] [Abstract][Full Text] [Related]
13. PEGylated Multistimuli-Responsive Dendritic Prodrug-Based Nanoscale System for Enhanced Anticancer Activity.
Duan Z; Cai H; Zhang H; Chen K; Li N; Xu Z; Gong Q; Luo K
ACS Appl Mater Interfaces; 2018 Oct; 10(42):35770-35783. PubMed ID: 30246536
[TBL] [Abstract][Full Text] [Related]
14. Rod-like cellulose nanocrystal/cis-aconityl-doxorubicin prodrug: A fluorescence-visible drug delivery system with enhanced cellular uptake and intracellular drug controlled release.
Li N; Lu W; Yu J; Xiao Y; Liu S; Gan L; Huang J
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():179-189. PubMed ID: 30033244
[TBL] [Abstract][Full Text] [Related]
15. pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects.
Lages EB; Fernandes RS; Andrade MMS; Paiyabhroma N; de Oliveira RB; Fernandes C; Cassali GD; Sicard P; Richard S; Branco de Barros AL; Ferreira LAM
Biomed Pharmacother; 2021 Dec; 144():112373. PubMed ID: 34794238
[TBL] [Abstract][Full Text] [Related]
16. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
[TBL] [Abstract][Full Text] [Related]
17. Brush-like Polymer Prodrug with Aggregation-Induced Emission Features for Precise Intracellular Drug Tracking.
Naghibi S; Sabouri S; Hong Y; Jia Z; Tang Y
Biosensors (Basel); 2022 May; 12(6):. PubMed ID: 35735521
[TBL] [Abstract][Full Text] [Related]
18. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.
Kim Y; Uthaman S; Pillarisetti S; Noh K; Huh KM; Park IK
Acta Biomater; 2020 May; 108():273-284. PubMed ID: 32205212
[TBL] [Abstract][Full Text] [Related]
19. A prodrug strategy based on chitosan for efficient intracellular anticancer drug delivery.
Chen C; Zhou JL; Han X; Song F; Wang XL; Wang YZ
Nanotechnology; 2014 Jun; 25(25):255101. PubMed ID: 24896540
[TBL] [Abstract][Full Text] [Related]
20. Design of light/ROS cascade-responsive tumor-recognizing nanotheranostics for spatiotemporally controlled drug release in locoregional photo-chemotherapy.
Zuo W; Chen D; Fan Z; Chen L; Zhu Z; Zhu Q; Zhu X
Acta Biomater; 2020 Jul; 111():327-340. PubMed ID: 32434075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
